期刊文献+

医院获得性支气管-肺感染老年患者病原菌特点及耐药性分析

Analysis of characteristics and resistance of pathogens for nosocomial pneumonia in old patients
原文传递
导出
摘要 目的:探讨医院获得性支气管-肺感染老年患者的病原菌菌株分布、耐药现状及治疗对策。方法:回顾性分析48例医院获得性支气管-肺感染老年患者痰液培养获得的52株致病菌的菌株分布及耐药性。结果:医院获得性支气管-肺感染老年患者的病原菌菌株分布前5位分别是:金黄色葡萄球菌(占21.15%)、大肠埃希菌(占17.30%)、铜绿假单胞菌(占15.38%)、鲍曼不动杆菌(占13.46%)、肺炎克雷伯菌(占11.54%);所有致病菌对常用抗生素耐药率均呈上升趋势,尚未发现耐万古霉素的MRSA菌株。结论:金黄色葡萄球菌、大肠埃希菌、铜绿假单胞菌、鲍曼不动杆菌、肺炎克雷伯菌是医院获得性支气管-肺感染老年患者的主要致病菌;应根据药敏试验合理使用抗生素,以减少医院获得性支气管-肺感染的发生、提高治愈率、控制致病菌日益增加的耐药趋势。 Objective:To discuss the distribution of the pathogens, the resistance pattern, and the counter measure of nosocomial pneumonia. Methods: The analysis of the distribution and the resistance of pathogens was conducted in retrospect of the 52 strains separated from the sputum of 48 patients of nosocomial pneumonia in cadre sickrooms of Maanshan central hospital. Results: The five most common pathogens in the analysis respectively were: Staphylococcus aureus 21.15%, Escheriehia coil 17.30 %, pseudomonas aeruginosa 15.38%, Acinetobacter baumannii 13.46%, Klebsiella pneumonia 11.54%. According to the drug sensitive test, all antimierobial resistant bacilli were increasing. None of the vancomycin resistant MRSA variant was seen. Conclusions: As regard to nosoeomial pneumonia, the most common pathogens are Staphylococcus aureus, Escherichia coli, pseudomonas aeruginosa, Acinetobaeter baumannii. In the course of treatment, effective and infection-control procedures, surveillance systems and appropriate antimicrobial selection must be emphasized so as to limit nosoeomial pneumonia pathogen occurrence.
作者 包满珍
出处 《中国冶金工业医学杂志》 2009年第3期261-262,共2页 Chinese Medical Journal of Metallurgical industry
关键词 老年患者 医院获得性支气管-肺感染 致病菌 耐药性 Old Nosocomial pneumia Pathogen Drug resistance
  • 相关文献

参考文献4

  • 1刘振声等主编..医院感染管理学[M].北京:军事医学科学出版社,2000:830.
  • 2中华医学会呼吸病学分会.医院内获得性肺感染诊断和治疗指南[J].中华结核和呼吸杂志,1999,22(4):201-201. 被引量:8
  • 3叶应妩、王毓三主编.全国临床检验操作规程[M].南京:东南大学出版社,1999:360~361 被引量:9
  • 4徐英春,王澎,陈民钧.286株肠杆菌科菌β-内酰胺酶及其耐药性的研究[J].中华医院感染学杂志,2004,14(4):447-449. 被引量:11

二级参考文献4

  • 1Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes[J], J Antimicrob Chemother(England), 2001,48,Suppl I, 87-102. 被引量:1
  • 2National Committee for Clinical Laboratory Standards. MIC testing supplement tables. M100-S13(M7).[S]. NCCLS, 2003. 被引量:1
  • 3Xu YC, Chen MJ, Douglas J, et al. Evaluation of the in vitro antimicrobial activity of cefepime compared to other broad-spectrum beta-lactams tested against recent clinical isolates from 10 Chinese hospitals[J]. Diagn Microbial Infect Dis,1999,35(2):135-1 被引量:1
  • 4Joshi M, Brull R, Sompali N, et al. Clinical outcomes of cefepime treatment on infections caused by ESBLs-and AmpC-producing Enterobacteriaceae[A]. 40th ICAAC, Abstract. 2000. 426. 被引量:1

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部